Home » Topics » BioWorld Science

BioWorld Science
RSS

JAK-3 inhibition prevents obliterative bronchiolitis after tracheal transplantation

June 2, 2004

PG-490-88 prolongs survival in renal allograft models

June 2, 2004

Praecis updates Plenaxis progress and highlights clinical program developments

June 2, 2004

LeuTech to be renamed NeutroSpec

June 2, 2004

Concurrent to acquire Allergan retinoid portfolio

June 2, 2004

Allergan and Kyorin sign Japanese agreement for Alphagan franchise

June 2, 2004

AOP and Lantibio enter licensing agreement for Moli-1901

June 2, 2004

Cizolirtine completes phase II trials in urinary incontinence

June 1, 2004

Pfizer claims novel p38 MAP kinase inhibitors in a recent patent

June 1, 2004

Roche researchers describe 5-HT receptor ligands for psychoses, dementia, etc.

June 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...